BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36455719)

  • 1. Analysis of the ability of vitamin D3-metabolizing cytochromes P450 to act on vitamin D3 sulfate and 25-hydroxyvitamin D3 3-sulfate.
    Tuckey RC; Cheng CYS; Li L; Jiang Y
    J Steroid Biochem Mol Biol; 2023 Mar; 227():106229. PubMed ID: 36455719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of vitamin D3 by cytochromes P450.
    Sakaki T; Kagawa N; Yamamoto K; Inouye K
    Front Biosci; 2005 Jan; 10():119-34. PubMed ID: 15574355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of purified CYP2R1 in a reconstituted membrane environment and its 25-hydroxylation of 20-hydroxyvitamin D3.
    Cheng CYS; Kim TK; Jeayeng S; Slominski AT; Tuckey RC
    J Steroid Biochem Mol Biol; 2018 Mar; 177():59-69. PubMed ID: 28716760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxylation of CYP11A1-derived products of vitamin D3 metabolism by human and mouse CYP27B1.
    Tang EK; Chen J; Janjetovic Z; Tieu EW; Slominski AT; Li W; Tuckey RC
    Drug Metab Dispos; 2013 May; 41(5):1112-24. PubMed ID: 23454830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of cholesterol, vitamin D3 and 20-hydroxyvitamin D3 incorporated into phospholipid vesicles by human CYP27A1.
    Tieu EW; Li W; Chen J; Baldisseri DM; Slominski AT; Tuckey RC
    J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):163-71. PubMed ID: 22210453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The serum vitamin D metabolome: What we know and what is still to discover.
    Tuckey RC; Cheng CYS; Slominski AT
    J Steroid Biochem Mol Biol; 2019 Feb; 186():4-21. PubMed ID: 30205156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-Mediated Gene Regulation of Vitamin D
    Norlin M; Lundqvist J; Ellfolk M; Hellström Pigg M; Gustafsson J; Wikvall K
    Basic Clin Pharmacol Toxicol; 2017 Jan; 120(1):59-63. PubMed ID: 27404500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation.
    Zbytek B; Janjetovic Z; Tuckey RC; Zmijewski MA; Sweatman TW; Jones E; Nguyen MN; Slominski AT
    J Invest Dermatol; 2008 Sep; 128(9):2271-80. PubMed ID: 18368131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte-derived cells express CYP27A1 and convert vitamin D3 into its active metabolite.
    Gottfried E; Rehli M; Hahn J; Holler E; Andreesen R; Kreutz M
    Biochem Biophys Res Commun; 2006 Oct; 349(1):209-13. PubMed ID: 16930540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of 22-hydroxy metabolites of vitamin d3 by cytochrome p450scc (CYP11A1) and analysis of their biological activities on skin cells.
    Tuckey RC; Li W; Shehabi HZ; Janjetovic Z; Nguyen MN; Kim TK; Chen J; Howell DE; Benson HA; Sweatman T; Baldisseri DM; Slominski A
    Drug Metab Dispos; 2011 Sep; 39(9):1577-88. PubMed ID: 21677063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of 20-hydroxyvitamin D3 and 20,23-dihydroxyvitamin D3 by rat and human CYP24A1.
    Tieu EW; Li W; Chen J; Kim TK; Ma D; Slominski AT; Tuckey RC
    J Steroid Biochem Mol Biol; 2015 May; 149():153-65. PubMed ID: 25727742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D metabolism and regulation in pediatric MSCs.
    Ruggiero B; Padwa BL; Christoph KM; Zhou S; Glowacki J
    J Steroid Biochem Mol Biol; 2016 Nov; 164():287-291. PubMed ID: 26385609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent studies on vitamin D metabolizing enzymes].
    Sakaki T
    Clin Calcium; 2006 Jul; 16(7):1129-35. PubMed ID: 16816472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D hydroxylases CYP2R1, CYP27B1 and CYP24A1 in renal cell carcinoma.
    Urbschat A; Paulus P; von Quernheim QF; Brück P; Badenhoop K; Zeuzem S; Ramos-Lopez E
    Eur J Clin Invest; 2013 Dec; 43(12):1282-90. PubMed ID: 24245571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired vitamin D activation and association with CYP24A1 haplotypes in differentiated thyroid carcinoma.
    Penna-Martinez M; Ramos-Lopez E; Stern J; Kahles H; Hinsch N; Hansmann ML; Selkinski I; Grünwald F; Vorländer C; Bechstein WO; Zeuzem S; Holzer K; Badenhoop K
    Thyroid; 2012 Jul; 22(7):709-16. PubMed ID: 22690899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased Serum 25-Hydroxyvitamin D in Aging Male Mice Is Associated With Reduced Hepatic Cyp2r1 Abundance.
    Roizen JD; Casella A; Lai M; Long C; Tara Z; Caplan I; O'Lear L; Levine MA
    Endocrinology; 2018 Aug; 159(8):3083-3089. PubMed ID: 29955863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo evidence for a novel pathway of vitamin D₃ metabolism initiated by P450scc and modified by CYP27B1.
    Slominski AT; Kim TK; Shehabi HZ; Semak I; Tang EK; Nguyen MN; Benson HA; Korik E; Janjetovic Z; Chen J; Yates CR; Postlethwaite A; Li W; Tuckey RC
    FASEB J; 2012 Sep; 26(9):3901-15. PubMed ID: 22683847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial.
    Barry EL; Rees JR; Peacock JL; Mott LA; Amos CI; Bostick RM; Figueiredo JC; Ahnen DJ; Bresalier RS; Burke CA; Baron JA
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E2133-7. PubMed ID: 25070320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression of vitamin D metabolic enzymes at baseline and in response to vitamin D treatment in thyroid cancer cell lines.
    Bennett RG; Wakeley SE; Hamel FG; High RR; Korch C; Goldner WS
    Oncology; 2012; 83(5):264-72. PubMed ID: 22992568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of vitamin D2 metabolites by human CYP24A1.
    Li L; Tuckey RC
    J Steroid Biochem Mol Biol; 2023 Oct; 233():106368. PubMed ID: 37495192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.